Litzka Olivier 4
4 · Mineralys Therapeutics, Inc. · Filed May 1, 2023
Insider Transaction Report
Form 4
Litzka Olivier
Director
Transactions
- Other
Stock Option
2023-04-27−44,000→ 0 totalExercise: $16.00Exp: 2033-02-09→ Common Stock (44,000 underlying)
Footnotes (2)
- [F1]Represents stock options transferred pursuant to an option transfer agreement between the Reporting Person and BioDiscovery 6 FCPI.
- [F2]The stock option vests in 36 monthly installments beginning on March 9, 2023.